Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CEP68 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DLAT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GIMAP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
STK36 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HIVEP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ZBTB21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP2R5C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MYLIP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCAN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POMZP3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LSM5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRCC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GPRIN3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARHGEF3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BHLHE22 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHAMP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP6C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DYRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IMPACT - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on